<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1197</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14978121</PubmedId>
            <Abstract>We measured CD8 T cell clonotypic diversity to three epitopes recognized in C57BL/6 mice infected with mouse hepatitis virus, strain JHM, or lymphocytic choriomeningitis virus. We isolated epitope-specific T cells with an IFN-gamma capture assay or MHC class I/peptide tetramers and identified different clonotypes by Vbeta chain sequence analysis. In agreement with our previous results, the number of different clonotypes responding to all three epitopes fit a log-series distribution. From these distributions, we estimated that &gt;1000 different clonotypes responded to each immunodominant CD8 T cell epitope; the response to a subdominant CD8 T cell epitope was modestly less diverse. These results suggest that T cell response diversity is greater by 1-2 orders of magnitude than predicted previously.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>3151-6</ArticlePages>
            <ArticleTitle>Very diverse CD8 T cell clonotypic responses after virus infections.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Pewe</LastName>
                    <ForeName>Lecia L</ForeName>
                </Author>
                <Author>
                    <LastName>Netland</LastName>
                    <ForeName>Jason M</ForeName>
                </Author>
                <Author>
                    <LastName>Heard</LastName>
                    <ForeName>Stephen B</ForeName>
                </Author>
                <Author>
                    <LastName>Perlman</LastName>
                    <ForeName>Stanley</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Peptide Fragments;Receptors, Antigen, T-Cell, alpha-beta;Viral Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; CD8-Positive T-Lymphocytes(immunology; metabolism; virology); Clone Cells; Coronavirus Infections(immunology; metabolism); Epitopes, T-Lymphocyte(immunology); Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Lymphocyte Activation; Lymphocyte Count(methods; statistics &amp; numerical data); Mice; Mice, Inbred C57BL; Murine hepatitis virus(immunology); Peptide Fragments(immunology); Poisson Distribution; Receptors, Antigen, T-Cell, alpha-beta(biosynthesis; genetics); Spleen(cytology; immunology; metabolism); Viral Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>172</Volume>
                <Issue>5</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>gp33</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KAVYNFATM</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC280130</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>11624</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 3152</LocationOfData>
                <EpitopeId>30015</EpitopeId>
                <ReferenceStartingPosition>33</ReferenceStartingPosition>
                <ReferenceEndingPosition>41</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1D</LocationOfData>
                        <TCellId>17104</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1 dose of 5x10&lt;sup&gt;5&lt;/sup&gt; PFU, in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>One week after immunization spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>gp33</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAVYNFATM</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280130</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>2.7% of CD8+ cells are peptide specific. Sequencing of the CDR3 Vbeta8 expressing cells, which comprise 30% of the total epitope specific population, yields between 223 and 469 different Vbeta8 clonotypes per spleen. Since the distribution of clonotypes fits a log distribution, it is estimated mathematically that between 1000 and 1200 different clonotypes per spleen are directed against this epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>S510</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CSLWNGPHL</LinearSequence>
                        <StartingPosition>510</StartingPosition>
                        <EndingPosition>518</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P22432.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11144</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 3151</LocationOfData>
                <EpitopeId>7032</EpitopeId>
                <ReferenceStartingPosition>510</ReferenceStartingPosition>
                <ReferenceEndingPosition>518</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Source protein Also known as E2 glycoprotein precursor, Spike glycoprotein and Peplomer protein. Source species Also known as Mouse hepatitis virus.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>17105</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11144</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1 dose of 5x10&lt;sup&gt;5&lt;/sup&gt; PFU, in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>One week after immunization spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>S510</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CSLWNGPHL</LinearSequence>
                                        <StartingPosition>510</StartingPosition>
                                        <EndingPosition>518</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P22432.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11144</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>4.6% of CD8+ cells are peptide specific. Sequencing of the CDR3 Vbeta13 expressing cells, which comprise 22% of the total epitope specific population, yields between 170 and 333 different Vbeta13 clonotypes per spleen. Since the distribution of clonotypes fits a log distribution, it is estimated mathematically that between 1150 and 1518 different clonotypes per spleen are directed against this epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>S598</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RCQIFANI</LinearSequence>
                        <StartingPosition>598</StartingPosition>
                        <EndingPosition>605</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P22432.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11144</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 3151</LocationOfData>
                <EpitopeId>53307</EpitopeId>
                <ReferenceStartingPosition>598</ReferenceStartingPosition>
                <ReferenceEndingPosition>605</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Source protein Also known as E2 glycoprotein precursor, Spike glycoprotein and Peplomer protein. Source species Also known as Mouse hepatitis virus.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Text and figure 2B</LocationOfData>
                        <TCellId>17106</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11144</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1 dose of 5x10&lt;sup&gt;5&lt;/sup&gt; PFU, in PBS</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>One week after immunization spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>S598</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RCQIFANI</LinearSequence>
                                        <StartingPosition>598</StartingPosition>
                                        <EndingPosition>605</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P22432.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11144</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sequencing of the CDR3 Vbeta5 from the epitope specific IFN-g+ population, yields between 141 and 332 different Vbeta5 clonotypes per spleen. Since the distribution of clonotypes fits a log distribution, it is estimated mathematically that between 582 and 889 different clonotypes per spleen are directed against this epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

